Amalgamated Bank’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $52K | Hold |
1,274
| – | – | ﹤0.01% | 1823 |
|
|
2025
Q1 | $65K | Buy |
1,274
+295
| +30% | +$15.1K | ﹤0.01% | 1751 |
|
|
2024
Q4 | $54K | Hold |
979
| – | – | ﹤0.01% | 1822 |
|
|
2024
Q3 | $32K | Hold |
979
| – | – | ﹤0.01% | 1981 |
|
|
2024
Q2 | $27K | Hold |
979
| – | – | ﹤0.01% | 2022 |
|
|
2024
Q1 | $36K | Sell |
979
-1,468
| -60% | -$54K | ﹤0.01% | 1947 |
|
|
2023
Q4 | $50K | Buy |
2,447
+163
| +7% | +$3.33K | ﹤0.01% | 2253 |
|
|
2023
Q3 | $41K | Buy |
2,284
+394
| +21% | +$7.07K | ﹤0.01% | 2334 |
|
|
2023
Q2 | $34K | Hold |
1,890
| – | – | ﹤0.01% | 2484 |
|
|
2023
Q1 | $24K | Sell |
1,890
-405
| -18% | -$5.14K | ﹤0.01% | 2585 |
|
|
2022
Q4 | $34K | Hold |
2,295
| – | – | ﹤0.01% | 2595 |
|
|
2022
Q3 | $39K | Hold |
2,295
| – | – | ﹤0.01% | 2567 |
|
|
2022
Q2 | $34K | Buy |
2,295
+989
| +76% | +$14.7K | ﹤0.01% | 2656 |
|
|
2022
Q1 | $22K | Buy |
+1,306
| New | +$22K | ﹤0.01% | 2782 |
|